Friday, October 13, 2017 3:56:41 AM
1) volume approached 8mm in two days (maybe too much even for more than one chat room);
2) we have seen the potential with this low float (11mm O/S) if a solid news will be released;
3) stock at these levels is massively undervalued. Less then 30mm market cap for a potential blockbuster drug and a very promising oncological drug
4) pps could hold the 2,5$ (still up 50% since last week) price recently accepted by TyrNovo investors. About that, my question is: would have you accepted shares at 2,5 (when it was traded at 1,9) instead of cash if you didn’t know what was their plan?
I think that the proposals recently approved and this restructuring (merging between the holding and the subsidiary) is part of something big in the future. In other words, it could be related to some deal. As we know, US and EU deal are ongoing.
In the meanwhile, we have to wait Renal results that if positive could give to KIT-302 a great value added.
Good luck!
EnricoMania
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM